Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

1

Closed

1

Total Settlement

$420M

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Class Action Lawsuit (September 2020)

Settlement

2:20cv4660 • September 23, 2020

Class Period Start

October 29, 2015

Class Period End

August 18, 2020

PSLRA Deadline

November 23, 2020

Case Allegations

10b5

Statutes of Repose

Oct 29, 2018

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

December 31, 1969

Settlement Fund

$0

Settlement Status

Class Certified

Settlement Class

Claim Administrator




Settlement Website

Hearing Date

December 31, 1969

Opt-out Deadline

December 31, 1969

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Nov 3, 2023

Class Certification Granted

The court has determined that a class action is the appropriate method to bring the claims by class members. Usually, when a class is certified, the judge will also affirm an individual or entity to represent the class and finalize a class definition (i.e.: who is represented in the lawsuit).

Sep 13, 2022

Motion for Class Certification

The plaintiffs have asked the court to approve the lawsuit to proceed as a class action on behalf of a group of investors. The judge will decide whether the case meets the requirements for class certification and which investors and claims may be included.

Mar 25, 2022

Motion to Dismiss Denied in Part

The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.

Aug 23, 2021

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

May 25, 2021

First Amended Complaint

A new complaint has been filed on behalf of certain investors in TEVA PHARMACEUTICAL INDUSTRIES LTD. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

View all Updates

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Class Action Lawsuit (November 2019)

Closed

3:17cv558 • November 8, 2019

Class Period Start

February 6, 2014

Class Period End

February 16, 2022

PSLRA Deadline

August 23, 2019

Case Allegations

10b5

Statutes of Repose

Feb 6, 2017

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

May 17, 2022

Settlement Fund

$420,000,000

Settlement Status

Disbursed

Settlement Class

All persons or entities that Purchasers and acquirers in domestic transactions of Teva Pharmaceutical Industries Ltd. (“Teva”) American Depositary Shares, Teva 7.00% mandatory convertible preferred shares, and/or certain Teva Pharmaceutical Finance Netherlands III B.V. (“Teva Finance”) U.S.-dollar-denominated senior notes during the period from February 6, 2014 through May 10, 2019, inclusive.

Claim Administrator

Epiq
Epiq Class Action & Claims Solutions, Inc. In re Teva Securities Litigation P.O. Box 3565 Portland, OR 97208-3565
+1 855-675-3124
[email protected]

Hearing Date

June 2, 2022

Opt-out Deadline

May 2, 2022

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Sep 18, 2023

Disbursement Approved

The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.

Jun 2, 2022

Final Approval of Settlement

The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.

Jan 27, 2022

Proof of Claim Form

To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.

Jan 27, 2022

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

Jan 18, 2022

Proposed Settlement

View all Updates

TOP